Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer

2025-521771-31-00 Protocol UMCG-NEOLYNC-001 Human pharmacology (Phase I) - Other Ongoing, recruiting

Start 5 Jan 2026 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol UMCG-NEOLYNC-001

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruiting
Participants planned 12
Countries 1
Sites 1

Cervical Cancer

Key facts

Sponsor
Universitair Medisch Centrum Groningen
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Female
Therapeutic area
Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13], Diseases [C] - Neoplasms [C04]
Trial duration
5 Jan 2026 → ongoing
Decision date (initial)
2025-08-19
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Cervical Cancer

VersionLevelCodeTermSystem organ class
21.1 LLT 10008238 Cervical carcinoma NOS 10029104

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Universitair Medisch Centrum Groningen

Sponsor organisation
Universitair Medisch Centrum Groningen
Address
Hanzeplein 1
City
Groningen
Postcode
9713 GZ
Country
Netherlands

Scientific contact point

Organisation
Universitair Medisch Centrum Groningen
Contact name
Prof. dr. H.W. Nijman

Public contact point

Organisation
Universitair Medisch Centrum Groningen
Contact name
Prof. dr. H.W. Nijman

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Netherlands Ongoing, recruiting 12 1
Rest of world 0

Investigational sites

Netherlands

1 site · Ongoing, recruiting
Universitair Medisch Centrum Groningen
Obstetrics & Gynecology, Hanzeplein 1, 9713 GZ, Groningen

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Netherlands 2026-01-05 2026-04-21

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-05-14 Netherlands Acceptable
2025-08-19
2025-08-19